{"id":8133,"date":"2026-10-23T08:00:00","date_gmt":"2026-10-23T06:00:00","guid":{"rendered":"https:\/\/chemspx.com\/?p=8133"},"modified":"2026-10-13T10:28:07","modified_gmt":"2026-10-13T08:28:07","slug":"how-are-receptor-media-selected-for-ivrt-and-ivpt-studies","status":"publish","type":"wiki_post","link":"https:\/\/chemspx.com\/fr\/wiki\/how-are-receptor-media-selected-for-ivrt-and-ivpt-studies\/","title":{"rendered":"How are receptor media selected for IVRT and IVPT studies?"},"content":{"rendered":"<p>Receptor media for IVRT and IVPT studies are selected based on their ability to maintain sink conditions, mimic physiological conditions, and accommodate the physicochemical properties of the active ingredient being tested. The receptor fluid must keep drug concentrations well below saturation throughout the experiment, ensuring that permeation or release is not artificially limited by the fluid itself. The sections below address the most important questions researchers face when choosing and validating receptor media for topical formulation testing.<\/p>\n<h2>What factors determine receptor media selection in IVRT and IVPT?<\/h2>\n<p>Receptor media selection in IVRT and IVPT is governed by three core factors: the solubility of the active substance, the need to maintain sink conditions, and the physiological relevance of the chosen fluid. The receptor phase must dissolve the permeating or released compound quickly enough to prevent back-diffusion, while remaining compatible with the membrane and the analytical detection method used.<\/p>\n<p>Beyond solubility, researchers must consider the physicochemical properties of the active ingredient, including its lipophilicity (expressed as log P), molecular weight, and ionization state at physiological pH. Highly lipophilic compounds, for example, often require the addition of solubilizing agents such as surfactants or cosolvents to achieve adequate sink conditions in an aqueous buffer. Poorly soluble compounds present the greatest challenge and typically demand the most careful optimization of the receptor phase composition.<\/p>\n<p>Membrane compatibility is another practical constraint. The receptor fluid must not swell, dissolve, or otherwise compromise the synthetic or biological membrane used in the Franz diffusion cell or comparable apparatus. Finally, the fluid must be compatible with the analytical technique used for quantification, whether that is HPLC, UV spectrophotometry, or another method, so that matrix effects are minimized.<\/p>\n<h2>What is the role of sink conditions in receptor fluid choice?<\/h2>\n<p>Sink conditions mean that the concentration of the drug in the receptor compartment remains low enough, typically below 10 to 20 percent of its saturation solubility, that the concentration gradient driving release or permeation is not diminished. Maintaining sink conditions is the single most critical requirement for a valid receptor fluid, because any accumulation of drug at the membrane-receptor interface will artificially slow the measured flux and distort the result.<\/p>\n<p>When a compound has limited water solubility, researchers achieve sink conditions by modifying the receptor fluid rather than simply increasing the volume of the compartment. Common strategies include adding a co-solvent such as ethanol or polyethylene glycol at a controlled concentration, incorporating a surfactant such as polysorbate 80, or using a cyclodextrin to complex the drug and keep it in solution. The choice of modifier must be justified scientifically: it should not alter membrane integrity, change the diffusion characteristics of the membrane, or interfere with downstream analysis.<\/p>\n<p>It is worth noting that sink conditions are a quantitative criterion, not a qualitative one. Researchers should calculate the theoretical maximum drug concentration expected in the receptor compartment over the duration of the study and confirm, through solubility measurements, that the chosen fluid provides a sufficient safety margin throughout the entire experiment, not just at the start.<\/p>\n<h2>How do IVRT and IVPT differ in receptor media requirements?<\/h2>\n<p>In vitro release testing (IVRT) measures how a drug is released from its formulation matrix, while in vitro permeation testing (IVPT) measures how a drug crosses a membrane into the receptor compartment. This fundamental difference means that IVPT places a stronger emphasis on physiological relevance in the receptor fluid, whereas IVRT prioritizes analytical sensitivity and sink maintenance above biological mimicry.<\/p>\n<p>For IVRT, the receptor fluid is primarily a collection medium. Because no biological membrane is involved in the rate-limiting step, the fluid simply needs to dissolve the released drug efficiently and support robust, reproducible quantification. Phosphate-buffered saline at pH 7.4 is widely used, but modified buffers or surfactant-containing media are acceptable as long as sink conditions are demonstrated and the method is validated.<\/p>\n<p>For IVPT, the receptor fluid is expected to approximate the conditions found in the viable epidermis and dermis. Studies using excised human or animal skin, or validated synthetic membranes, require a receptor phase that supports the physiological transport environment. This often means using isotonic phosphate buffer at physiological pH, sometimes supplemented with a small percentage of a solubilizer for poorly soluble compounds. The choice must be justified in the context of the membrane used and the intended clinical or regulatory application.<\/p>\n<h2>Which buffer systems and additives are most commonly used?<\/h2>\n<p>The most commonly used receptor fluid in both IVRT and IVPT is phosphate-buffered saline (PBS) at pH 7.4, reflecting physiological conditions in skin tissue. For compounds with low aqueous solubility, researchers frequently supplement PBS with surfactants, cosolvents, or protein-containing solutions to achieve and maintain sink conditions throughout the study.<\/p>\n<p>The most frequently encountered additives in topical formulation testing include:<\/p>\n<ul>\n <li><strong>Polysorbate 80 (Tween 80)<\/strong> at concentrations typically between 0.1 and 5 percent, used for lipophilic actives<\/li>\n <li><strong>Ethanol or polyethylene glycol 400<\/strong> as water-miscible cosolvents at controlled percentages<\/li>\n <li><strong>Hydroxypropyl-beta-cyclodextrin<\/strong>, which complexes poorly soluble drugs and keeps them in solution without disrupting membrane integrity<\/li>\n <li><strong>Bovine serum albumin (BSA)<\/strong>, which mimics protein binding in the dermis and is particularly relevant for IVPT studies using biological membranes<\/li>\n <li><strong>Isotonic saline<\/strong> without buffer salts, used when the compound is highly soluble and no pH adjustment is needed<\/li>\n<\/ul>\n<p>The concentration of any additive must be optimized carefully. Too little will fail to maintain sink conditions; too much may alter membrane permeability, interfere with the analytical method, or be difficult to justify to a regulatory reviewer. All additives and their concentrations should be reported transparently in the study protocol and the final method documentation.<\/p>\n<h2>What do FDA and EMA guidelines say about receptor fluid selection?<\/h2>\n<p>Both the FDA and EMA require that the receptor fluid be scientifically justified and capable of maintaining sink conditions for the duration of the study. Neither agency mandates a single universal receptor fluid, recognizing that the appropriate choice depends on the physicochemical properties of the active substance and the formulation type under investigation.<\/p>\n<p>The FDA&#8217;s guidance on topical drug products, including its recommendations for IVRT as a surrogate for bioequivalence, emphasizes that the receptor fluid composition must be reported and that sink conditions must be demonstrated experimentally, not merely assumed. The agency expects that any deviation from a simple physiological buffer is supported by solubility data and a scientific rationale.<\/p>\n<p>The EMA&#8217;s guidance on quality and equivalence of topical products similarly stresses that the receptor phase should be physiologically relevant where possible, and that the use of solubilizers should be minimized to the extent consistent with maintaining sink conditions. Both agencies expect the receptor fluid to be part of the validated method, meaning its composition is fixed and any change would require revalidation.<\/p>\n<p>Regulatory reviewers in both jurisdictions pay close attention to whether the receptor fluid could artificially enhance or suppress permeation, particularly when surfactants or organic solvents are used. Transparency in reporting and a clear scientific rationale are the two elements that carry the most weight in regulatory submissions involving IVRT or IVPT data.<\/p>\n<h2>How should receptor media selection be validated for a study?<\/h2>\n<p>Receptor media selection is validated by demonstrating, through a series of targeted experiments, that the chosen fluid maintains sink conditions, does not compromise membrane integrity, and supports accurate and reproducible quantification of the drug throughout the study duration. Validation is not a single experiment but a structured sequence of assessments performed before the main study begins.<\/p>\n<p>A systematic validation approach typically follows these steps:<\/p>\n<ol>\n <li><strong>Solubility determination:<\/strong> Measure the equilibrium solubility of the active compound in the proposed receptor fluid at the study temperature (usually 32 to 37 degrees Celsius). Confirm that the expected maximum drug concentration in the receptor compartment remains well below the saturation limit.<\/li>\n <li><strong>Sink condition confirmation:<\/strong> Run a preliminary permeation or release experiment and monitor drug accumulation in the receptor over time. Confirm that concentrations do not approach the saturation threshold at any time point.<\/li>\n <li><strong>Membrane integrity check:<\/strong> Verify that the receptor fluid does not cause visible or measurable changes to the membrane, particularly for biological membranes used in IVPT. Transepidermal water loss (TEWL) measurements or electrical resistance checks are standard approaches.<\/li>\n <li><strong>Analytical method compatibility:<\/strong> Confirm that the receptor fluid matrix does not interfere with the quantification method. This includes running matrix-matched calibration standards and evaluating recovery and precision.<\/li>\n <li><strong>Stability assessment:<\/strong> Test the stability of the drug in the receptor fluid at the study temperature over the full duration of the experiment. Degradation in the receptor compartment would lead to underestimation of flux.<\/li>\n<\/ol>\n<p>Documenting each of these steps rigorously is essential, both for internal quality assurance and for regulatory submissions. In GLP-compliant studies, the receptor fluid composition and the validation data supporting its selection form part of the study protocol and must be archived alongside the raw data.<\/p>\n<h2>How ChemSPX supports in vitro permeation and release testing workflows<\/h2>\n<p>Laboratories in the Benelux working on topical formulation development often face practical challenges when setting up or optimizing IVRT and IVPT workflows, from selecting the right diffusion cell configuration to ensuring that the receptor phase is correctly specified for the compound and membrane in question. ChemSPX works with research teams across the Benelux region to address these challenges through:<\/p>\n<ul>\n <li>Expert advice on instrument selection and configuration for Franz diffusion cell studies and related permeation testing setups<\/li>\n <li>Application-level support for researchers optimizing receptor fluid composition and analytical integration<\/li>\n <li>Installation and qualification services (IQ\/OQ) to ensure instruments perform to specification from day one<\/li>\n <li>Ongoing service and calibration support to keep equipment reliable and compliant with GMP and GLP requirements<\/li>\n<\/ul>\n<p>Whether you are establishing a new IVPT method or scaling up an existing IVRT workflow, the ChemSPX team is available to discuss your specific requirements. <a href=\"https:\/\/chemspx.com\/fr\/contact\/\">Contact ChemSPX<\/a> to speak with a specialist about your topical formulation testing needs in the Benelux.<\/p>\n<div class=\"wp-block-seoaic-faq-block\">\n    <h2 class=\"seoaic-faq-section-title\">Foire aux questions<\/h2>\n            <div class=\"seoaic-faq-item\">\n            <h3 class=\"seoaic-question\">\n                Can I use the same receptor fluid for both IVRT and IVPT studies on the same compound?            <\/h3>\n            <p class=\"seoaic-answer\">\n                Not necessarily. While the same base buffer (e.g., PBS at pH 7.4) is often used as a starting point for both study types, IVPT may require additional physiological relevance that IVRT does not. For example, a receptor fluid optimized purely for sink maintenance in an IVRT study may not adequately mimic dermal conditions for an IVPT study using excised skin. Always evaluate the fluid independently for each study type, considering the membrane used, the regulatory context, and the intended application of the data.            <\/p>\n        <\/div>\n                <div class=\"seoaic-faq-item\">\n            <h3 class=\"seoaic-question\">\n                What is a practical starting point for receptor fluid selection when working with a poorly soluble compound for the first time?            <\/h3>\n            <p class=\"seoaic-answer\">\n                Begin by measuring the equilibrium solubility of your compound in plain PBS at pH 7.4 and calculate whether that solubility provides at least a 10-fold safety margin over the expected maximum receptor concentration. If it does not, incrementally add a solubilizer \u2014 starting with a low concentration of polysorbate 80 (e.g., 0.5%) or hydroxypropyl-beta-cyclodextrin \u2014 and re-measure solubility at each step until the margin is achieved. This stepwise approach keeps the formulation as simple as possible, which is easier to justify scientifically and to defend in a regulatory submission.            <\/p>\n        <\/div>\n                <div class=\"seoaic-faq-item\">\n            <h3 class=\"seoaic-question\">\n                How do I know if a surfactant or cosolvent I&#039;ve added to the receptor fluid is affecting membrane integrity?            <\/h3>\n            <p class=\"seoaic-answer\">\n                For biological membranes used in IVPT, transepidermal water loss (TEWL) measurements and electrical resistance (e.g., via skin impedance testing) before and after exposure to the receptor fluid are the standard approaches for detecting membrane damage. For synthetic membranes, gravimetric assessment (checking for swelling or weight change) and visual inspection are practical first checks. If any of these indicators show significant changes, the additive concentration should be reduced or an alternative solubilizer should be evaluated.            <\/p>\n        <\/div>\n                <div class=\"seoaic-faq-item\">\n            <h3 class=\"seoaic-question\">\n                What happens if sink conditions are lost partway through a long-duration study?            <\/h3>\n            <p class=\"seoaic-answer\">\n                If drug concentrations in the receptor compartment approach or exceed 10\u201320% of saturation solubility during the study, the concentration gradient driving permeation or release is reduced, and the measured flux will be artificially suppressed from that point onward \u2014 making the data unreliable for the later time points. To prevent this, calculate the worst-case cumulative drug load in the receptor compartment before the study begins, and if necessary, increase sampling frequency, reduce the dose applied, or reformulate the receptor fluid to provide a larger solubility margin. Retroactively correcting for lost sink conditions is not straightforward and is unlikely to be accepted by regulatory reviewers.            <\/p>\n        <\/div>\n                <div class=\"seoaic-faq-item\">\n            <h3 class=\"seoaic-question\">\n                Are there any additives that regulatory agencies are particularly cautious about, and how should I address this in my submission?            <\/h3>\n            <p class=\"seoaic-answer\">\n                Both the FDA and EMA scrutinize the use of organic solvents and high concentrations of surfactants in receptor fluids, as these can alter membrane permeability and artificially inflate or suppress flux measurements. To address this proactively in a submission, include solubility data demonstrating why the additive was necessary, specify the exact concentration used, and provide experimental evidence (e.g., a comparison experiment or literature reference) showing that the additive at the chosen concentration does not measurably alter membrane behavior. Transparency and a clear scientific rationale are consistently the most effective strategies with regulatory reviewers.            <\/p>\n        <\/div>\n                <div class=\"seoaic-faq-item\">\n            <h3 class=\"seoaic-question\">\n                How often should the receptor fluid be sampled or replaced during a Franz diffusion cell study, and does this affect sink conditions?            <\/h3>\n            <p class=\"seoaic-answer\">\n                Sampling intervals are typically dictated by the expected permeation or release kinetics of the compound and the sensitivity of the analytical method, but common time points range from 1 to 24 hours depending on the study design. Each time a sample is withdrawn, the removed volume should be replaced with fresh receptor fluid to maintain a constant compartment volume and to help sustain sink conditions. Failing to replace withdrawn volume can concentrate the remaining drug and accelerate the loss of sink conditions, particularly in longer studies with rapidly permeating compounds.            <\/p>\n        <\/div>\n                <div class=\"seoaic-faq-item\">\n            <h3 class=\"seoaic-question\">\n                Can receptor fluid composition be changed after method validation has been completed?            <\/h3>\n            <p class=\"seoaic-answer\">\n                No \u2014 changing the receptor fluid composition after validation is completed constitutes a method change and requires revalidation of the affected parameters, including sink condition confirmation, membrane integrity, and analytical compatibility. For GLP-compliant studies, any such change must also be documented as a protocol amendment. This is why it is worth investing time upfront to optimize and stress-test the receptor fluid before locking the method, rather than making adjustments once validation data have already been generated.            <\/p>\n        <\/div>\n        <\/div>","protected":false},"template":"","class_list":["post-8133","wiki_post","type-wiki_post","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>How are receptor media selected for IVRT and IVPT studies? | ChemSPX<\/title>\n<meta name=\"description\" content=\"Receptor media selection for IVRT and IVPT depends on sink conditions, solubility, and regulatory fit. Learn which buffers and additives work best. Read the full guide.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/chemspx.com\/fr\/wiki\/how-are-receptor-media-selected-for-ivrt-and-ivpt-studies\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"How are receptor media selected for IVRT and IVPT studies? | ChemSPX\" \/>\n<meta property=\"og:description\" content=\"Receptor media selection for IVRT and IVPT depends on sink conditions, solubility, and regulatory fit. Learn which buffers and additives work best. Read the full guide.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/chemspx.com\/fr\/wiki\/how-are-receptor-media-selected-for-ivrt-and-ivpt-studies\/\" \/>\n<meta property=\"og:site_name\" content=\"ChemSPX\" \/>\n<meta property=\"og:image\" content=\"https:\/\/chemspx.com\/wp-content\/uploads\/2026\/10\/franz-diffusion-cell-receptor-fluid-lab.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"768\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"12 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/chemspx.com\\\/fr\\\/wiki\\\/how-are-receptor-media-selected-for-ivrt-and-ivpt-studies\\\/\",\"url\":\"https:\\\/\\\/chemspx.com\\\/fr\\\/wiki\\\/how-are-receptor-media-selected-for-ivrt-and-ivpt-studies\\\/\",\"name\":\"How are receptor media selected for IVRT and IVPT studies? | ChemSPX\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/chemspx.com\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/chemspx.com\\\/fr\\\/wiki\\\/how-are-receptor-media-selected-for-ivrt-and-ivpt-studies\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/chemspx.com\\\/fr\\\/wiki\\\/how-are-receptor-media-selected-for-ivrt-and-ivpt-studies\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/chemspx.com\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/franz-diffusion-cell-receptor-fluid-lab.webp\",\"datePublished\":\"2026-10-23T06:00:00+00:00\",\"description\":\"Receptor media selection for IVRT and IVPT depends on sink conditions, solubility, and regulatory fit. Learn which buffers and additives work best. Read the full guide.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/chemspx.com\\\/fr\\\/wiki\\\/how-are-receptor-media-selected-for-ivrt-and-ivpt-studies\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/chemspx.com\\\/fr\\\/wiki\\\/how-are-receptor-media-selected-for-ivrt-and-ivpt-studies\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/chemspx.com\\\/fr\\\/wiki\\\/how-are-receptor-media-selected-for-ivrt-and-ivpt-studies\\\/#primaryimage\",\"url\":\"https:\\\/\\\/chemspx.com\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/franz-diffusion-cell-receptor-fluid-lab.webp\",\"contentUrl\":\"https:\\\/\\\/chemspx.com\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/franz-diffusion-cell-receptor-fluid-lab.webp\",\"width\":1024,\"height\":768,\"caption\":\"Franz diffusion cell filled with clear receptor fluid, surrounded by membrane filters and scientific glassware in a laboratory setting.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/chemspx.com\\\/fr\\\/wiki\\\/how-are-receptor-media-selected-for-ivrt-and-ivpt-studies\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/chemspx.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Wiki post\",\"item\":\"https:\\\/\\\/chemspx.com\\\/Wiki\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"How are receptor media selected for IVRT and IVPT studies?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/chemspx.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/chemspx.com\\\/fr\\\/\",\"name\":\"ChemSPX\",\"description\":\"ChemSPX\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/chemspx.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"How are receptor media selected for IVRT and IVPT studies? | ChemSPX","description":"Receptor media selection for IVRT and IVPT depends on sink conditions, solubility, and regulatory fit. Learn which buffers and additives work best. Read the full guide.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/chemspx.com\/fr\/wiki\/how-are-receptor-media-selected-for-ivrt-and-ivpt-studies\/","og_locale":"fr_FR","og_type":"article","og_title":"How are receptor media selected for IVRT and IVPT studies? | ChemSPX","og_description":"Receptor media selection for IVRT and IVPT depends on sink conditions, solubility, and regulatory fit. Learn which buffers and additives work best. Read the full guide.","og_url":"https:\/\/chemspx.com\/fr\/wiki\/how-are-receptor-media-selected-for-ivrt-and-ivpt-studies\/","og_site_name":"ChemSPX","og_image":[{"width":1024,"height":768,"url":"https:\/\/chemspx.com\/wp-content\/uploads\/2026\/10\/franz-diffusion-cell-receptor-fluid-lab.webp","type":"image\/webp"}],"twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"12 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/chemspx.com\/fr\/wiki\/how-are-receptor-media-selected-for-ivrt-and-ivpt-studies\/","url":"https:\/\/chemspx.com\/fr\/wiki\/how-are-receptor-media-selected-for-ivrt-and-ivpt-studies\/","name":"How are receptor media selected for IVRT and IVPT studies? | ChemSPX","isPartOf":{"@id":"https:\/\/chemspx.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/chemspx.com\/fr\/wiki\/how-are-receptor-media-selected-for-ivrt-and-ivpt-studies\/#primaryimage"},"image":{"@id":"https:\/\/chemspx.com\/fr\/wiki\/how-are-receptor-media-selected-for-ivrt-and-ivpt-studies\/#primaryimage"},"thumbnailUrl":"https:\/\/chemspx.com\/wp-content\/uploads\/2026\/10\/franz-diffusion-cell-receptor-fluid-lab.webp","datePublished":"2026-10-23T06:00:00+00:00","description":"Receptor media selection for IVRT and IVPT depends on sink conditions, solubility, and regulatory fit. Learn which buffers and additives work best. Read the full guide.","breadcrumb":{"@id":"https:\/\/chemspx.com\/fr\/wiki\/how-are-receptor-media-selected-for-ivrt-and-ivpt-studies\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/chemspx.com\/fr\/wiki\/how-are-receptor-media-selected-for-ivrt-and-ivpt-studies\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/chemspx.com\/fr\/wiki\/how-are-receptor-media-selected-for-ivrt-and-ivpt-studies\/#primaryimage","url":"https:\/\/chemspx.com\/wp-content\/uploads\/2026\/10\/franz-diffusion-cell-receptor-fluid-lab.webp","contentUrl":"https:\/\/chemspx.com\/wp-content\/uploads\/2026\/10\/franz-diffusion-cell-receptor-fluid-lab.webp","width":1024,"height":768,"caption":"Franz diffusion cell filled with clear receptor fluid, surrounded by membrane filters and scientific glassware in a laboratory setting."},{"@type":"BreadcrumbList","@id":"https:\/\/chemspx.com\/fr\/wiki\/how-are-receptor-media-selected-for-ivrt-and-ivpt-studies\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/chemspx.com\/"},{"@type":"ListItem","position":2,"name":"Wiki post","item":"https:\/\/chemspx.com\/Wiki\/"},{"@type":"ListItem","position":3,"name":"How are receptor media selected for IVRT and IVPT studies?"}]},{"@type":"WebSite","@id":"https:\/\/chemspx.com\/fr\/#website","url":"https:\/\/chemspx.com\/fr\/","name":"ChemSPX","description":"ChemSPX","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/chemspx.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"_links":{"self":[{"href":"https:\/\/chemspx.com\/fr\/wp-json\/wp\/v2\/wiki_post\/8133","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/chemspx.com\/fr\/wp-json\/wp\/v2\/wiki_post"}],"about":[{"href":"https:\/\/chemspx.com\/fr\/wp-json\/wp\/v2\/types\/wiki_post"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/chemspx.com\/fr\/wp-json\/wp\/v2\/media\/8178"}],"wp:attachment":[{"href":"https:\/\/chemspx.com\/fr\/wp-json\/wp\/v2\/media?parent=8133"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}